Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells

Molecular Cancer
John Patrick AlaoDavid M Vigushin

Abstract

Cyclin D1 is an important regulator of G1-S phase cell cycle transition and has been shown to be important for breast cancer development. GSK3beta phosphorylates cyclin D1 on Thr-286, resulting in enhanced ubiquitylation, nuclear export and degradation of the cyclin in the cytoplasm. Recent findings suggest that the development of small-molecule cyclin D1 ablative agents is of clinical relevance. We have previously shown that the histone deacetylase inhibitor trichostatin A (TSA) induces the rapid ubiquitin-dependent degradation of cyclin D1 in MCF-7 breast cancer cells prior to repression of cyclin D1 gene (CCND1) transcription. TSA treatment also resulted in accumulation of polyubiquitylated GFP-cyclin D1 species and reduced levels of the recombinant protein within the nucleus. Here we provide further evidence for TSA-induced ubiquitin-dependent degradation of cyclin D1 and demonstrate that GSK3beta-mediated nuclear export facilitates this activity. Our observations suggest that TSA treatment results in enhanced cyclin D1 degradation via the GSK3beta/CRM1-dependent nuclear export/26S proteasomal degradation pathway in MCF-7 cells. We have demonstrated that rapid TSA-induced cyclin D1 degradation in MCF-7 cells requires GSK3be...Continue Reading

References

May 1, 1993·Genes & Development·V BaldinG Draetta
Jul 1, 1997·The Journal of Clinical Investigation·N E TawaA L Goldberg
Nov 14, 1997·The Journal of Biological Chemistry·Y H ChoiJ B Trepel
Sep 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·Z K YuH Zhang
Oct 28, 1998·Trends in Cell Biology·D H Lee, A L Goldberg
Jul 1, 1999·Genes & Development·C J Sherr, J M Roberts
Apr 15, 2000·The Journal of Biological Chemistry·D GermainJ Hendley
Aug 22, 2001·Chemistry & Biology·A F Kisselev, A L Goldberg
Dec 26, 2001·The Journal of Biological Chemistry·Jodi R AltJ Alan Diehl
Apr 4, 2003·The International Journal of Biochemistry & Cell Biology·Cezary Wójcik, George N DeMartino
May 15, 2003·The Journal of Biological Chemistry·David A SolomonErik S Knudsen
Aug 2, 2003·Cancer Cell·Ricky W Johnstone, Jonathan D Licht
Apr 13, 2004·The Journal of Biological Chemistry·Yonglong ZouEileen Friedman
Apr 28, 2004·Bioorganic & Medicinal Chemistry Letters·Charles M MarsonDavid M Vigushin
May 28, 2004·Expert Opinion on Pharmacotherapy·Paul G Richardson
Jul 28, 2004·The Journal of Biological Chemistry·Ruchi M NewmanBruce R Zetter
Dec 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John Patrick AlaoDavid M Vigushin
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·Daryl C DrummondChristopher C Benz
Jun 18, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew Arnold, Alexandros Papanikolaou

❮ Previous
Next ❯

Citations

Jul 21, 2012·Journal of Cancer Research and Clinical Oncology·Xiaobo ZhangSeung Joon Baek
Jan 28, 2012·Journal of Medicinal Chemistry·Matthias G J BaudMatthew J Fuchter
Jan 17, 2007·Cell Division·Olena BarbashJ Alan Diehl
Jun 8, 2013·World Journal of Gastroenterology : WJG·Yu-Gang WangMin Shi
Nov 12, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hanieh JafaryMasoud Soleimani
Dec 29, 2010·Journal of Biomedicine & Biotechnology·Aurélien LinaresVincent Cavailles
Feb 7, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rathi N PillaiJohann C Brandes
Jun 15, 2010·Cell Cycle·Prashant V BommiGoberdhan P Dimri
Mar 14, 2018·Bioinformatics·Azam PeyvandipourSorin Draghici
Nov 18, 2014·Molecular Carcinogenesis·Y B RenH Y Wang
Feb 13, 2016·Chonnam Medical Journal·Somy Yoon, Gwang Hyeon Eom
Sep 7, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Moonmoon DebSamir Kumar Patra
Jun 19, 2012·Clinical Epigenetics·Zhi-Yi GuoFang Yang
Feb 6, 2019·Proceedings of the National Academy of Sciences of the United States of America·Asaf SolRalph R Isberg
Nov 2, 2020·Molecular Pharmacology·Kanchan VishnoiBasabi Rana
Aug 5, 2021·Molecular Carcinogenesis·Xiao HuYue Wang
Sep 28, 2021·Technology in Cancer Research & Treatment·Jiancong HuHuanliang Liu

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence microscopy
PCR
transfection

Related Concepts

Related Feeds

Cell Cycle Control & Proteolysis

Key regulators of cell cycle, including cyclins, cyclin dependent kinase inhibitors, DNA replication factors, are controlled by proteolysis. Discover the latest research on cell cycle control and proteolysis.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.